Correlation Between Inhibrx and Biofrontera
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Biofrontera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Biofrontera into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Biofrontera, you can compare the effects of market volatilities on Inhibrx and Biofrontera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Biofrontera. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Biofrontera.
Diversification Opportunities for Inhibrx and Biofrontera
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Inhibrx and Biofrontera is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Biofrontera in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofrontera and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Biofrontera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofrontera has no effect on the direction of Inhibrx i.e., Inhibrx and Biofrontera go up and down completely randomly.
Pair Corralation between Inhibrx and Biofrontera
Given the investment horizon of 90 days Inhibrx is expected to generate 0.38 times more return on investment than Biofrontera. However, Inhibrx is 2.63 times less risky than Biofrontera. It trades about -0.03 of its potential returns per unit of risk. Biofrontera is currently generating about -0.06 per unit of risk. If you would invest 1,580 in Inhibrx on September 2, 2024 and sell it today you would lose (54.00) from holding Inhibrx or give up 3.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Biofrontera
Performance |
| Timeline |
| Inhibrx |
| Biofrontera |
Inhibrx and Biofrontera Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Biofrontera
The main advantage of trading using opposite Inhibrx and Biofrontera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Biofrontera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera will offset losses from the drop in Biofrontera's long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Biofrontera vs. Tff Pharmaceuticals | Biofrontera vs. Eliem Therapeutics | Biofrontera vs. Inhibrx | Biofrontera vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |